Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans-Georg Rammensee

Showing results (1-10 of 293) with videos related to

Pageof 30
Sort By:
Immunity|November 14, 2006
Peptides made to orderHans-Georg Rammensee
Nature|January 16, 2004
Immunology: protein surgeryHans-Georg Rammensee
Immunology and Cell Biology|May 10, 2006
Some considerations on the use of peptides and mRNA for therapeutic vaccination against cancerHans-Georg Rammensee
Novartis Foundation Symposium|January 10, 2004
Immunoinformatics: bioinformatic strategies for better understanding of immune function. IntroductionHans-Georg Rammensee
Nature|October 9, 2002
Survival of the fittersHans-Georg Rammensee
Cancer Immunology, Immunotherapy : CII|April 13, 2018
Personalized cancer vaccines: adjuvants are important, tooCécile Gouttefangeas, Hans-Georg Rammensee
Immunogenetics|March 5, 2025
Kirsten Falk 1963-2024Hans-Georg Rammensee, Olaf Rötzschke
Immunogenetics|October 22, 2018
Contribution of the plasma and lymph Degradome and Peptidome to the MHC LigandomeLaura Santambrogio, Hans-Georg Rammensee
Expert Review of Vaccines|October 5, 2013
HLA ligandome tumor antigen discovery for personalized vaccine approachHans-Georg Rammensee, Harpreet Singh-Jasuja
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|October 9, 2020
[Individualized immunotherapy for malignant tumors using peptide vaccines-maybe it does work after all?]Hans-Georg Rammensee, Markus W Löffler
Pageof 30

Showing results (1-10 of 293) with videos related to

Sort By:
Pageof 30
Immunity|November 14, 2006
Peptides made to orderHans-Georg Rammensee
Nature|January 16, 2004
Immunology: protein surgeryHans-Georg Rammensee
Immunology and Cell Biology|May 10, 2006
Some considerations on the use of peptides and mRNA for therapeutic vaccination against cancerHans-Georg Rammensee
Novartis Foundation Symposium|January 10, 2004
Immunoinformatics: bioinformatic strategies for better understanding of immune function. IntroductionHans-Georg Rammensee
Nature|October 9, 2002
Survival of the fittersHans-Georg Rammensee
Cancer Immunology, Immunotherapy : CII|April 13, 2018
Personalized cancer vaccines: adjuvants are important, tooCécile Gouttefangeas, Hans-Georg Rammensee
Immunogenetics|March 5, 2025
Kirsten Falk 1963-2024Hans-Georg Rammensee, Olaf Rötzschke
Immunogenetics|October 22, 2018
Contribution of the plasma and lymph Degradome and Peptidome to the MHC LigandomeLaura Santambrogio, Hans-Georg Rammensee
Expert Review of Vaccines|October 5, 2013
HLA ligandome tumor antigen discovery for personalized vaccine approachHans-Georg Rammensee, Harpreet Singh-Jasuja
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|October 9, 2020
[Individualized immunotherapy for malignant tumors using peptide vaccines-maybe it does work after all?]Hans-Georg Rammensee, Markus W Löffler
Pageof 30